Serum Institute CEO Poonawalla delighted at Oxford vaccine’s trial results, says Covishield to be widely available

Health
Typography

The Serum Institute of India is India’s partner of Oxford University and AstraZeneca to produce the anti-COVID-19 and has already manufactured millions of doses of the vaccine

Pune-based Serum Institute of India's CEO Adar Poonawalla on Monday said he is 'delighted' that Covishield , the vaccine against COVID-19 being developed by Oxford University and AstraZeneca, will offer protection up to 90 percent protection against coronavirus.

“I am delighted to hear that, Covishield, a low-cost, logistically manageable & soon to be widely available, #COVID19 vaccine, will offer protection up to 90% in one type of dosage regime and 62% in the other dosage regime. Further details on this, will be provided this evening," said Poonawalla.

The Serum Institute of India, the world's largest vaccine manufacturer, is India’s partner of Oxford University and AstraZeneca to produce the anti-COVID-19 and has already manufactured millions of doses of the vaccine.

Britain-based AstraZeneca has signed several supply and manufacturing deals with companies and governments around the world.

The University of Oxford, in collaboration with AstraZeneca plc, on Monday announced that their vaccine against COVID-19 has been found to be effective up to 90 during its Phase III trials.

The interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection, said University of Oxford in a statement.

Serum Institute would seek emergency use authorisation for the AstraZeneca vaccine as soon as authorities in the United Kingdom approved it and made it available for the general public, Poonawalla was quoted as saying in Mint last week.

The vaccine would be priced between $5-$6 in the retail market, but the Indian government would get it for much less, because they would buy it bulk, Poonawaala said.

It would take at least two to three years for all of India's 1.3 billion population to be covered, he said.

Image credit: Twitter

All Comments